These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2004-002260-25||A randomized, phase III, double blind, active-controlled, two-armed, multi-center study on efficacy and safety of once-daily oxcarbazepine (-modified release formulation) versus twice-daily oxcarbazep...||2005-10-01||due-trials|
|Not reported Terminated||2006-003834-14||Safety and Efficacy of Novel Modified Release Formulation of Oxacarbazepine (OXC MR) vs an Immediate Release Oxacarbazepine (OXC IR) Product in Patients with Partial Epilepsy. Open-Labelled, Controlle...||2010-04-01||due-trials|
|Not reported||2009-012419-16||Influence of the Non-Ergot Dopamine agonist Piribedil on vigilance and cognitive function in patients with Parkinson's disease compared to other oral Non-Ergot Dopamine agonists||2011-12-07||due-trials|
|Completed, report not yet due||2017-004767-13||A randomized, placebo-controlled, multiple dose, double blind, phase IIb, dose guiding trial to explore safety and tolerability of four weeks treatment with sulthiame in patients with moderate to seve...||2019-12-19||not-yet-due|